RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY

项目摘要/摘要 加州大学旧金山分校风湿病中心的精准医学中心Premier(P30)提供了至关重要的 资源和专业知识使尖端研究能够推进风湿病的精准医学 疾病。Premier汇集了临床专业知识、明确的患者队列、最先进的 与生物信息学和综合分析专家合作的免疫表型和基因组技术。这 基础设施促进协作研究，可集成大量临床和分子数据 需要对推动临床表型异质性的生物学有更基本的了解 以及风湿病患者的治疗反应。总理寻求降低门槛 通过提供对相关资源的访问以及使用这些资源的专业知识来从事风湿学研究 恰如其分。 我们的中心包括三个资源核心，每个资源核心将提供咨询，以指导研究人员进行研究 设计、分析并获得形成所需协作所需的重要专业知识和协助。这个 临床数据和信息学核心(CDI)，由吉努斯·亚兹达尼博士指导，将提供临床研究和 信息学服务，包括访问大型风湿病数据库、生物检疫和 用于研究发现的电子健康记录数据；基因组技术核心(GT)，由Dr. 吉米·叶和沃尔特·埃卡尔巴将开发新的基因组技术并建立专门的工作流程 和为风湿病研究设计的分析路径；以及综合生物信息学核心 (IB)，由Marina Sirota博士和Gabriela Fragiadakis博士共同执导，将解决高级 生物信息学专业知识，特别是在单细胞分析、多组学综合分析和使用方面 公开可用的数据。总理行政核心由Mary Nakamura博士(主任)和Dr Nakamura博士领导。 吉努斯·亚兹达尼(协理主任)，并向中心提供领导和组织监督。这个 CORE包括一个重要的丰富计划，包括研讨会、年度研讨会、由 资源核心、指导计划和赠款计划，包括开发和可行性试点赠款 和核心使用拨款。Premier利用大量重要的加州大学旧金山分校和分部资源，这些资源 与Premier资源核心提供的服务高度协同。 鉴于我们的过往记录和对创新的坚定承诺，Premier准备吸引新的 研究人员和风湿病研究进一步推进，朝着改善的最终目标前进 通过对基础疾病的详细阐述来诊断和治疗风湿病 机械装置。

PROJECT SUMMARY/ABSTRACT PREMIER, the UCSF Precision Medicine in Rheumatology Center (P30), provides critically important resources and expertise to enable cutting-edge research to advance precision medicine in the rheumatic diseases. PREMIER brings together clinical expertise, defined patient cohorts, state-of-the-art immunophenotyping and genomic technologies with experts in bioinformatics and integrative analyses. This infrastructure facilitates collaborative studies that can integrate the large amounts of clinical and molecular data needed to gain a more fundamental understanding of the biology driving the heterogeneity of clinical phenotypes and treatment responses among individuals with rheumatic disease. PREMIER seeks to lower the barriers to pursuing rheumatology research by providing access to relevant resources along with the expertise to use them appropriately. Our Center includes three Resource Cores that will each provide consultation to guide investigators in study design, analysis, and access to significant expertise and assistance in forming the collaborations needed. The Clinical Data and Informatics Core (CDI), directed by Dr. Jinoos Yazdany, will provide clinical research and informatics services including access to large rheumatic diseases databases, biospecimens and curation of electronic health record data for research discovery; the Genomic Technology Core (GT), co-directed by Drs. Jimmie Ye and Walter Eckalbar, will develop novel genomic technologies and institute specialized workflows and analytic pathways designed for the study of rheumatic diseases; and the Integrative Bioinformatics Core (IB), co-directed by Drs. Marina Sirota and Gabriela Fragiadakis, will address investigator needs for advanced bioinformatics expertise, particularly with regard to single cell analytics, multi-omic integrative analysis, and use of publicly available data. PREMIER’s Administrative Core is led by Dr. Mary Nakamura (Director) and Dr. Jinoos Yazdany (Associate Director) and provides leadership and organizational oversight to the Center. The Core includes a significant enrichment program involving seminars, an annual symposium, workshops led by the Resource Cores, a mentoring program, and a grant program including Development and Feasibility Pilot grants and Core Usage Grants. PREMIER leverages a number of significant UCSF and divisional resources that are highly synergistic with the services offered in PREMIER Resource Cores. Given our track record and deep commitment to innovation, PREMIER is poised to attract new investigators and further advance rheumatology research towards the ultimate goal of improving diagnosis and treatment of rheumatic disease through the detailed elucidation of underlying disease mechanisms.